NeuroShield Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Liquidation

NeuroShield General Information

Description

Developer of a chitosan-based membrane designed to help in peripheral nerve repair. The company's membrane shields nerves from further damage and promotes fast regrowth, enabling patients to have accelerated recovery from nerve damage.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Platz 4, D4
  • 6039 Root
  • Switzerland
+41 041
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Parent Company
Vertical(s)
Corporate Office
  • Platz 4, D4
  • 6039 Root
  • Switzerland
+41 041

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroShield Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 07-Apr-2024 Completed Bankruptcy: Liquidation
4. Merger/Acquisition 12-Aug-2021 Completed Generating Revenue
3. Early Stage VC 28-Sep-2020 Completed Generating Revenue
2. Early Stage VC 20-Jul-2017 $1.48M $1.48M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view NeuroShield’s complete valuation and funding history, request access »

NeuroShield Patents

NeuroShield Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3972562-A1 Medical device comprising a chitosan-based support structure Active 22-May-2019
EP-3972562-B1 Medical device comprising a chitosan-based support structure Active 22-May-2019
US-12569590-B2 Medical device comprising a chitosan-based support structure Active 22-May-2019
US-20220218870-A1 Medical device comprising a chitosan-based support structure Active 22-May-2019
WO-2020234740-A1 Medical device comprising a chitosan-based support structure Inactive 22-May-2019 A61L27/26
To view NeuroShield’s complete patent history, request access »

NeuroShield Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fast Track Venture Venture Capital Minority
Global Emerging Markets PE/Buyout Minority
Technopark Luzern Accelerator/Incubator
To view NeuroShield’s complete investors history, request access »

NeuroShield FAQs

  • When was NeuroShield founded?

    NeuroShield was founded in 2016.

  • Where is NeuroShield headquartered?

    NeuroShield is headquartered in Root, Switzerland.

  • What industry is NeuroShield in?

    NeuroShield’s primary industry is Therapeutic Devices.

  • Is NeuroShield a private or public company?

    NeuroShield is a Private company.

  • What is NeuroShield’s current revenue?

    The current revenue for NeuroShield is .

  • How much funding has NeuroShield raised over time?

    NeuroShield has raised $25.1M.

  • Who are NeuroShield’s investors?

    Fast Track Venture, Global Emerging Markets, and Technopark Luzern have invested in NeuroShield.

  • When was NeuroShield acquired?

    NeuroShield was acquired on 07-Apr-2024.

  • Who acquired NeuroShield?

    NeuroShield was acquired by Checkpoint Surgical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process